Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;21(4):222-230.
doi: 10.1089/met.2023.0002. Epub 2023 Apr 20.

Association of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children

Affiliations

Association of Hepatic Steatosis with Adipose and Muscle Mass and Distribution in Children

Ghattas J Malki et al. Metab Syndr Relat Disord. 2023 May.

Abstract

Background: Pediatric studies have shown associations between hepatic steatosis and total body fat, visceral fat, and lean mass. However, these associations have not been assessed simultaneously, leaving their relative importance unknown. Objective: To evaluate associations between hepatic steatosis and total-body adiposity, visceral adiposity, and lean mass in children. Method: In children at risk for fatty liver, hepatic steatosis, adipose, and lean mass were estimated with magnetic resonance imaging and dual-energy X-ray absorptiometry. Results: Two hundred twenty-seven children with mean age 12.1 years had mean percent body fat of 38.9% and mean liver fat of 8.4%. Liver fat was positively associated with total-body adiposity, visceral adiposity, and lean mass (P < 0.001), and negatively associated with lean mass percentage (P < 0.001). After weight adjustment, liver fat was only positively associated with measures of central adiposity (P < 0.001). Visceral adiposity also had the strongest association with liver fat (P < 0.001). Conclusions: In children, hepatic steatosis is more strongly associated with visceral adiposity than total adiposity, and the association of lean mass is not independent of weight or fat mass. These relationships may help guide the choice of future interventions to target hepatic steatosis.

Keywords: MRI-PDFF; adipose; hepatic steatosis; muscle; nonalcoholic fatty liver disease.

PubMed Disclaimer

Conflict of interest statement

C.B.S. reports grants to UCSD from American College of Radiology, GE, Siemens, Philips, Bayer, Foundation of NIH, Gilead, and Pfizer; personal consultation fees from Blade, Boehringer, and Epigenomics; consultation under the auspices of the University to AMRA, BMS, Exact Sciences, GE Digital, IBM-Watson, and Pfizer; laboratory service agreements to UCSD from Enanta, Gilead, ICON, Intercept, NuSirt, Shire, Synageva, and Takeda; royalties from Wolters Kluwer for educational material outside the submitted work; honoraria to the UCSD from Medscape for educational material outside the submitted work; pending position as Chief Medical Officer for Livivos; ownership of stock options in Livivos; and unpaid position in advisory board to Quantix Bio.

M.S.M. reports personal consultation fees from Alimentiv, Arrowhead, Glympse, Kowa, Median, and Novo Nordisk; laboratory services agreement through UCSD from Alexion, Astra Zeneca, Bristol-Myers Squibb, Celgene, Enanta, Galmed, Genzyme, Gilead, Intercept, Ionis, Janssen, NuSirt, Organovo, Pfizer, Roche, Sanofi, Shire, Synageva, Takeda, and Quantix Bio; grants to UCSD from Guerbet and Pfizer; personal fees from Livivos and Pfizer, outside the submitted work.

J.B.S. reports grants to UCSD from Intercept, Genfit, and Seraphina, outside the submitted work. All other authors have no conflicts of interest relevant to this article to disclose.

Figures

FIG. 1.
FIG. 1.
Study flow diagram showing the recruitment of participants in terms of screening, exclusion, and inclusion. DXA, dual-energy X-ray absorptiometry.

References

    1. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008;94(2):231–241. - PubMed
    1. Lindbäck SM, Gabbert C, Johnson BL, et al. . Pediatric nonalcoholic fatty liver disease: A comprehensive review. Adv Pediatr 2010;57(1):85–140. - PubMed
    1. Sanyal AJ; American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705–1725. - PubMed
    1. Schwimmer JB, Deutsch R, Kahen T, et al. . Prevalence of fatty liver in children and adolescents. Pediatrics 2006;118(4):1388–1393. - PubMed
    1. Sahota AK, Shapiro WL, Newton KP, et al. . Incidence of nonalcoholic fatty liver disease in children: 2009–2018. Pediatrics [Internet]. [cited 2021 Sep 5]. 2020;146(6). Available from: https://pediatrics.aappublications.org/content/146/6/e20200771 [Last accessed: September 5, 2021]. - PMC - PubMed

Publication types